Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Brazeau

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Toxicology and Applied Pharmacology|March 1, 1994
Solvent-dependent influences on skeletal muscle sarcoplasmic reticulum calcium uptake and releaseA Chu, G A Brazeau
Pharmaceutical Research|September 1, 1989
Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systemsG A Brazeau, H L Fung
Journal of Pharmaceutical Sciences|May 1, 1990
Mechanisms of creatine kinase release from isolated rat skeletal muscles damaged by propylene glycol and ethanolG A Brazeau, H L Fung
The Biochemical Journal|January 15, 1989
Interferences with assay of creatine kinase activity in vitroG A Brazeau, H L Fung
American Pharmacy|December 1, 1995
Genetically engineered vaccinesJ A Hughes, G A Brazeau
Journal of Pharmaceutical Sciences|September 1, 1990
Effect of organic cosolvent-induced skeletal muscle damage on the bioavailability of intramuscular [14C]diazepamG A Brazeau, H L Fung
Pharmacological Reviews|May 18, 2001
Clinical pharmacology of the dietary supplement creatine monohydrateA M Persky, G A Brazeau
Pharmaceutical Research|February 1, 1989
An in vitro model to evaluate muscle damage following intramuscular injectionsG A Brazeau, H L Fung
Journal of Parenteral Science and Technology : a Publication of the Parenteral Drug Association|July 1, 1989
Physicochemical properties of binary organic cosolvent-water mixtures and their relationships to muscle damage following intramuscular injectionG A Brazeau, H L Fung
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 1, 1996
Vaccines on the horizon: HIV and cancerG A Brazeau, J A Hughes
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Toxicology and Applied Pharmacology|March 1, 1994
Solvent-dependent influences on skeletal muscle sarcoplasmic reticulum calcium uptake and releaseA Chu, G A Brazeau
Pharmaceutical Research|September 1, 1989
Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systemsG A Brazeau, H L Fung
Journal of Pharmaceutical Sciences|May 1, 1990
Mechanisms of creatine kinase release from isolated rat skeletal muscles damaged by propylene glycol and ethanolG A Brazeau, H L Fung
The Biochemical Journal|January 15, 1989
Interferences with assay of creatine kinase activity in vitroG A Brazeau, H L Fung
American Pharmacy|December 1, 1995
Genetically engineered vaccinesJ A Hughes, G A Brazeau
Journal of Pharmaceutical Sciences|September 1, 1990
Effect of organic cosolvent-induced skeletal muscle damage on the bioavailability of intramuscular [14C]diazepamG A Brazeau, H L Fung
Pharmacological Reviews|May 18, 2001
Clinical pharmacology of the dietary supplement creatine monohydrateA M Persky, G A Brazeau
Pharmaceutical Research|February 1, 1989
An in vitro model to evaluate muscle damage following intramuscular injectionsG A Brazeau, H L Fung
Journal of Parenteral Science and Technology : a Publication of the Parenteral Drug Association|July 1, 1989
Physicochemical properties of binary organic cosolvent-water mixtures and their relationships to muscle damage following intramuscular injectionG A Brazeau, H L Fung
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 1, 1996
Vaccines on the horizon: HIV and cancerG A Brazeau, J A Hughes
Pageof 3